You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Colorcon
Dow
Mallinckrodt
Moodys
McKinsey
Johnson and Johnson

Last Updated: May 31, 2020

DrugPatentWatch Database Preview

Litigation Details for LUPIN ATLANTIS HOLDINGS S.A. v. APOTEX INC. (E.D. Pa. 2011)


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

LUPIN ATLANTIS HOLDINGS S.A. v. APOTEX INC. (E.D. Pa. 2011)

Docket   Start Trial Date Filed 2011-03-18
Court District Court, E.D. Pennsylvania Date Terminated 2011-06-07
Cause 35:271 Patent Infringement Assigned To Gene E.K. Pratter
Jury Demand Defendant Referred To
Parties APOTEX CORP.; APOTEX INC.; ETHYPHARM S.A.; LUPIN ATLANTIS HOLDINGS S.A.
Patents 4,058,552; 4,800,079; 4,895,726; 5,145,684; 5,545,628; 6,074,670; 6,277,405; 9,061,005
Attorneys CHRISTOPHER T. GRIFFITH; JAMAICA P. SZELIGA; JEFFREY A. COHEN; JENNIFER C. TEMPESTA; JOHN J. HIGSON; KATE M. LESCIOTTO; LISA KOLE; PAUL A. RAGUSA; ROBERT F. GREEN; WILLIAM E. MAHONEY , JR.
Firms Baker Botts, LLP; Dilworth Paxson LLP (PA); Flaster Greenberg, Pc; Leydig Voit & Mayer Ltd; Robert F. Green; Stradley, Ronon, Stevens & Young, LLP
Link to Docket External link to docket
Small Molecule Drugs cited in LUPIN ATLANTIS HOLDINGS S.A. v. APOTEX INC.
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .
Biologic Drugs cited in LUPIN ATLANTIS HOLDINGS S.A. v. APOTEX INC.
The biologic drug covered by the patents cited in this case is   Start Trial .

Details for LUPIN ATLANTIS HOLDINGS S.A. v. APOTEX INC. (E.D. Pa. 2011)

Date Filed Document No. Description Snippet Link To Document
2011-03-18 1 References Cited U.S. PATENT DOCUMENTS 3,914,286 A 10/1975 Mieville 4,058,552 A 11/1977 Mieville 4,344,934…lnventors: Bruno Criere, Gravigny (FR); Pascal 4.058,552 A 11/1977 Mieville Suplie, Montaure (FR); Philippe… of U.S. Patent 7,101,574 (“the ’574 patent”) and U.S. Patent No. 7,863,331 (“the ’331 patent”). This …United States Patent (10) Patent No.: US 7,101,574 B1 Criere et al. (45) Date of Patent: Sep. 5, 2006 …active ingredient THE PATENTS-IN-SUIT 27. On September 5 , 2006, the U.S. Patent and Trademark Office External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Colorcon
McKinsey
Dow
Medtronic
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.